A lifesaving finding - During Breast Cancer Awareness Month, St. Joseph’s patient Barbara Moscovich is telling the world about the discovery of a tiny dot with big implications for women with dense breasts

London, Ontario – It was startlingly clear – a tiny bright dot stood out starkly amid the grey waves and shades on the image. Unseen on every other exam, something was definitively there.

It was a lifesaving finding for Barbara Moscovich – a tumour pinpointed using contrast-enhanced mammography at St. Joseph’s Hospital where women are benefitting from the latest in breast imaging technology.

Barbara, 75, has faithfully undergone regular breast screening for more than three decades. Three years ago, due to extremely dense breasts, it was advised she have a mammogram every year instead of every two years. It wasn’t enough to catch a good size lump on her left breast, which was discovered last year during a physical exam by her family doctor. During the follow up with mammography and ultrasound on both breasts, the lump in the left breast was visible on ultrasound, but barely seen on her mammogram. There was also a hint of something suspicious on the right that was eluding detection.

“The radiologist couldn’t really see it on the ultrasound so suggested contrast-enhanced mammography,” says Barbara. “Sure enough, a very very tiny tumour showed up just under the nipple. The images were amazing, so clear despite my very ‘busy’ breasts.”

Both lumps were cancerous and Barbara underwent a lumpectomy on each breast on Dec. 27, 2019, followed by partial breast radiation. She will be on an anti-estrogen hormone medication for the next seven years and monitored closely.

Barbara’s story is being shared worldwide through a docuseries being launched this month by GE Healthcare, maker of the Senographe Pristina mammography machine, a groundbreaking new breast imaging platform. In 2017, St. Joseph's became first hospital in Canada to install a Pristina unit. The following year, additional Pristina units were installed with the added capability of performing contrast-enhanced mammograms and tomosynthesis (three-dimensional mammography). In June 2020, St. Joseph’s became the first hospital in North America to perform a biopsy guided by contrast- enhanced mammography. Donor dollars to St. Joseph’s Health Care Foundation have made these breast imaging breakthroughs possible.

Contrast-enhanced mammography combines conventional digital diagnostic mammography with the administration of a contrast agent, explains Dr. Anat Kornecki, Breast Radiology Lead with St. Joseph’s Breast Care Program. The contrast agent – radiographic dye containing iodine – is injected into a vein in the patient’s arm before the mammogram images are taken.

With contrast-enhanced mammography, the area of concern within the breast is highlighted in much more detail and can be an alternative to MRI, says Dr. Kornecki. It can pinpoint cancers that can’t be seen with standard mammography and is particularly effective in assessing dense breasts. Those considered for contrast mammography are patients who have had a screening mammogram that indicated something suspicious, or those who present with breast symptoms. At this time, it is not used for regular screening.

“After three years of using contrast-enhanced mammography I can say that this is a game changer in the world of breast imaging,” says Dr. Kornecki. “Similar to MRI, it can detect many more cancers than standard mammography and ultrasound and, at the same time, it allows us to reach a final diagnosis and provide treatment more rapidly."

Now an advocate for better screening for women with dense breasts, Barbara says many women are unaware that dense breasts not only make it harder for radiologists to spot tumours, the actual risk of cancer for those with dense breasts is higher. Many also don’t know they have dense breasts despite its prevalence (more than 40 per cent of women have dense breasts) and the information being available on the mammogram reports sent to family doctors.

“It should be flagged by family doctors, women informed and information available,” says Barbara, a retired teacher and principal. “I had to find out a whole lot of information on my own. My advice is for women to ask the question – ‘How dense are my breasts?’”

As a patient of St. Joseph’s Breast Care Program, adds the lifelong learner, “I couldn’t have been in a better place to benefit from the latest and best in breast imaging.”


Read more about Barbara in our stories section of St. Joseph’s website.

Members of the media are welcome to interview Barbara and Dr. Kornecki on this important topic. To arrange, please contact:

Dahlia Reich, Communication & Public Affairs
St. Joseph’s Health Care London
519 646-6100 ext. 65294, cell 519 619 0971

About St. Joseph’s Health Care London

Renowned for compassionate care, St. Joseph’s Health Care London is a leading academic health care centre in Canada dedicated to helping people live to their fullest by minimizing the effects of injury, disease and disability through excellence in care, teaching and research. Through partnership with Lawson Health Research Institute and our collaborative engagement with other health care and academic partners, St. Joseph’s has become an international leader in the areas of: chronic disease management; medical imaging; specialized mental health care; rehabilitation and specialized geriatrics; and surgery. St. Joseph’s operates through a wide range of hospital, clinic and long-term and community based settings, including: St. Joseph’s Hospital; Parkwood Institute; Mount Hope Centre for Long Term Care; and the Southwest Centre for Forensic Mental Health Care. Visit www.sjhc.london.on.ca  for more information.

Share this news articleBack to all News